LPL Financial’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Other funds holding OTLK
PA
HF
GWM
LPL Financial's OTLK Position: Q2 2026 in Review
LPL Financial increased its Outlook Therapeutics (OTLK) stake by 450% in Q2 2026, buying an estimated $93.8K and bringing the position to 184,942 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #5476.
LPL Financial first reported a position in OTLK in Q1 2020 and has held it in 20 quarters since. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.
- LPL Financial held 184,942 shares of Outlook Therapeutics worth $294K as of Q2 2026.
- LPL Financial bought 151,315 Outlook Therapeutics shares in Q2 2026, an estimated $93.8K.
- Outlook Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5476 holding.
- LPL Financial first reported a position in Outlook Therapeutics in Q1 2020 and has held it in 20 quarters since.
- 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.